[1] R C WILLIS J E S D A Carson. Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1978, 75 7: 3042-3044. DOI:
10.1073/pnas.75.7.3042[2] D G STREETER. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1973, 70 4: 1174-1178. DOI:
10.1073/pnas.70.4.1174[3] CLERCQ E D. Specific targets for antiviral drugs.[J]. Biochemical Journal, 1982, 205 1: 1-13. DOI:
10.1042/bj2050001[4] J. BALZARINI. Mechanism of the potentiating effect of ribavirin on the activity of 2’,3’-dideoxyinosine against human immunodeficiency virus.[J]. The Journal of Biological Chemistry, 1991, 27 1: 21509-21514. DOI:
10.1016/s0021-9258(18)54668-8[5] BROWNE M J. Mechanism and specificity of action of ribavirin.[J]. Antimicrobial Agents and Chemotherapy, 1979, 15 6: 747-753. DOI:
10.1128/aac.15.6.747